APIs & Bulk Drugs Supplier in China
Active pharmaceutical ingredients and bulk drugs sourced from Indian manufacturers, with COA, pharmacopoeial specs and regulatory documents on request. Formulation and generic manufacturers in China source APIs from us with batch COAs and, where the producing site holds them, DMF or CEP support.
APIs & Bulk Drugs for China
The APIs and bulk drugs division supplies active pharmaceutical ingredients across major therapeutic classes, including anti-infectives, cardiovascular, antidiabetic, analgesic, gastrointestinal and CNS molecules. India is one of the world's largest API producing countries, and we source from manufacturers in established clusters such as Hyderabad, Vizag, Gujarat and Maharashtra.
Materials are offered to IP, BP, USP or Ph. Eur. monographs, or to in-house specifications where no monograph exists. Every shipment carries the manufacturer's batch COA and a GHS SDS. Depending on the product and the producing site, supporting documents such as a DMF letter of access, CEP, GMP certificate, EU written confirmation, TSE/BSE and residual solvent statements may be available. Availability is confirmed per product before you order, never assumed. We also help buyers assemble sample quantities for pre-qualification testing before a commercial order is placed.
Formulation manufacturers, generic companies developing dossiers, compounding and veterinary producers, and research groups needing reference quantities are the main buyers. Import of APIs is regulated in almost every market, so importers should confirm local licence, registration and site-approval requirements. We provide documents in the format the buyer's regulatory team requests where the manufacturer allows it.
Grades available
Compliance in China
Regulator: NMPA
Substances not listed on the Inventory of Existing Chemical Substances in China (IECSC) need new chemical substance registration with the Ministry of Ecology and Environment before import. Hazardous chemicals are subject to GACC (former CIQ) inspection of packaging and Chinese-language labels and SDS, and APIs need NMPA registration or linkage to a drug filing. Precursor chemicals require import licences, and dangerous goods must follow IMDG or IATA rules. APTA preference requires a certificate of origin.
Shipping lanes
- Shanghai
- Ningbo-Zhoushan
- Shenzhen
- Shanghai Pudong (PVG)
- Beijing Capital (PEK)
Typical buyers: Finished dosage formulators, Generic dossier developers, Veterinary drug manufacturers, Nutraceutical and compounding companies, Pharma distributors and importers, R&D and pilot-scale labs.
Browse APIs & Bulk Drugs categories
Selected APIs & Bulk Drugs shipped to China
FAQs — APIs & Bulk Drugs in China
Do you supply APIs & Bulk Drugs to China?
Yes. We export APIs & Bulk Drugs to China by sea freight to Shanghai or Ningbo-Zhoushan, by air cargo, or by express courier for small R&D packs. Every shipment includes a COA and a GHS SDS.
How long does delivery to China take?
Typical sea transit from India to China is 18–26 days and air freight 3–5 days, plus production/packing lead time and customs clearance.
Can you provide a DMF or CEP for an API?
It depends on the product and the manufacturing site. Where the manufacturer holds a US DMF, CEP or other filing, a letter of access or copy can often be arranged. We confirm availability per product before quoting.
Which pharmacopoeial standards do your APIs meet?
APIs are offered to IP, BP, USP or Ph. Eur. monographs as stated on the quotation and COA, and to manufacturer specifications where no monograph applies.
Do I need an import licence to buy APIs?
In most countries yes. Importers typically need a drug import or wholesale licence and sometimes site registration of the manufacturer. Please check requirements with your local regulator before ordering.
Other divisions for China
APIs & Bulk Drugs in nearby markets
APIs & Bulk Drugs quote — China
We reply within one business day with price, pack options, lead time and documentation.